Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_assertion type Assertion NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_head.
- NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_assertion description "[Several ongoing programs aim to develop LBD independent therapeutic strategies that for example target the N terminus domain (NTD) of the AR or chaperone proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_provenance.
- NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_assertion evidence source_evidence_literature NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_provenance.
- NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_assertion SIO_000772 23565754 NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_provenance.
- NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_assertion wasDerivedFrom befree-20140225 NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_provenance.
- NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_assertion wasGeneratedBy ECO_0000203 NP212520.RAe7GXbOeIvCJN1g_XmmzS6l6EHZi3efwNxJiVOOtkdXI130_provenance.